Journal Home > Volume 18 , Issue 1
OBJECTIVE

In patients undergoing cardiac surgery, reduced preoperative ejection fraction (EF) and senior age are associated with a worse outcome. As most outcome data available for these patients are mainly from Western surgical populations involving specific surgery types, our aim is to evaluate the real-world characteristics and perioperative outcomes of surgery in senior-aged heart failure patients with reduced EF across a broad range cardiac surgeries.

METHODS

Data were obtained from the China Heart Failure Surgery Registry (China-HFSR) database, a nationwide multicenter registry study in mainland China. Multiple variable regression analysis was performed in patients over 75 years old to identify risk factors associated with mortality.

RESULTS

From 2012 to 2017, 578 senior-aged (> 75 years) patients were enrolled in China HFSR, 21.1% of whom were female. Isolated coronary bypass grafting (CABG) were performed in 71.6% of patients, 10.1% of patients underwent isolated valve surgery and 8.7% received CABG combined with valve surgery. In-hospital mortality was 10.6%, and the major complication rate was 17.3%. Multivariate analysis identified diabetes mellitus (odds ratio (OR) = 1.985), increased creatinine (OR = 1.007), New York Heart Association (NYHA) Class III (OR = 1.408), NYHA class IV (OR = 1.955), cardiogenic shock (OR, 6.271), and preoperative intra-aortic balloon pump insertion (OR = 3.426) as independent predictors of in-hospital mortality.

CONCLUSIONS

In senior-aged patients, preoperative evaluation should be carefully performed, and strict management of reversible factors needs more attention. Senior-aged patients commonly have a more severe disease status combined with more frequent comorbidities, which may lead to a high risk in mortality.


menu
Abstract
Full text
Outline
Electronic supplementary material
About this article

Outcomes of cardiac surgery in senior aged patients with ventricular dysfunction: analysis of a large national database

Show Author's information Han-Wei TANG1Kai CHEN1Jian-Feng HOU1Xiao-Hong HUANG2Sheng LIU1Han-Ping MA1Sheng-Shou HU1( )
Department of Cardiovascular Surgery, National Center for Cardiovascular Diseases, State Key Laboratory of Cardiovascular Disease, Fuwai Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China
Department of Special Medical Treatment Center, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Science and Peking Union Medical College, Beijing, China

Abstract

OBJECTIVE

In patients undergoing cardiac surgery, reduced preoperative ejection fraction (EF) and senior age are associated with a worse outcome. As most outcome data available for these patients are mainly from Western surgical populations involving specific surgery types, our aim is to evaluate the real-world characteristics and perioperative outcomes of surgery in senior-aged heart failure patients with reduced EF across a broad range cardiac surgeries.

METHODS

Data were obtained from the China Heart Failure Surgery Registry (China-HFSR) database, a nationwide multicenter registry study in mainland China. Multiple variable regression analysis was performed in patients over 75 years old to identify risk factors associated with mortality.

RESULTS

From 2012 to 2017, 578 senior-aged (> 75 years) patients were enrolled in China HFSR, 21.1% of whom were female. Isolated coronary bypass grafting (CABG) were performed in 71.6% of patients, 10.1% of patients underwent isolated valve surgery and 8.7% received CABG combined with valve surgery. In-hospital mortality was 10.6%, and the major complication rate was 17.3%. Multivariate analysis identified diabetes mellitus (odds ratio (OR) = 1.985), increased creatinine (OR = 1.007), New York Heart Association (NYHA) Class III (OR = 1.408), NYHA class IV (OR = 1.955), cardiogenic shock (OR, 6.271), and preoperative intra-aortic balloon pump insertion (OR = 3.426) as independent predictors of in-hospital mortality.

CONCLUSIONS

In senior-aged patients, preoperative evaluation should be carefully performed, and strict management of reversible factors needs more attention. Senior-aged patients commonly have a more severe disease status combined with more frequent comorbidities, which may lead to a high risk in mortality.

References(34)

[1]
National Health and Family Planning Commission of PRC China Health and Family Planning Statistical Yearbook. 2016.
[2]

Li Z, Bian Y, Zeng L, et al. Life Expectancy, Causes of Death, Risk Factors in China and the U.S. Ann Glob Health 2017; 83: 407−414.

[3]

Hu S, Gao R, Liu L, et al. Abstract of Report on Cardiovascular Diseases in China (2018). Chinese Circulation Journal 2019; 34: 209−20.

[4]

Keeling WB, Williams ML, Slaughter MS, et al. Off-pump and on-pump coronary revascularization in patients with low ejection fraction: a report from the society of thoracic surgeons national database. Ann Thorac Surg 2013; 96: 83−88.

[5]

Alexander KP, Anstrom KJ, Muhlbaier LH, et al. Outcomes of cardiac surgery in patients > or = 80 years: results from the National Cardiovascular Network. J Am Coll Cardiol 2000; 35: 731−738.

[6]

Pieri M, Belletti A, Monaco F, et al. Outcome of cardiac surgery in patients with low preoperative ejection fraction. BMC Anesthesiol 2016; 16: 97.

[7]

Maltais S, Schaff HV, Daly RC, et al. Mitral regurgitation surgery in patients with ischemic cardiomyopathy and ischemic mitral regurgitation: factors that influence survival. J Thorac Cardiovasc Surg 2011; 142: 995−1001.

[8]

Naughton C, Feneck RO, Roxburgh J. Early and late predictors of mortality following on-pump coronary artery bypass graft surgery in the elderly as compared to a younger population. Eur J Cardiothorac Surg 2009; 36: 621−627.

[9]

Cook C, Cole G, Asaria P, et al. The annual global economic burden of heart failure. Int J Cardiol 2014; 171: 368−376.

[10]

Zheng Z, Zhang H, Yuan X, et al. Comparing Outcomes of Coronary Artery Bypass Grafting Among Large Teaching and Urban Hospitals in China and the United States. Circ Cardiovasc Qual Outcomes 2017; 10: e003327-e.

[11]

Zheng Z, Li Y, Zhang S, et al. The Chinese coronary artery bypass grafting registry study: how well does the EuroSCORE predict operative risk for Chinese population? Eur J Cardiothorac Surg 2009; 35: 54−58.

[12]

Yancy CW, Jessup M, Bozkurt B, et al. 2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines. Circulation 2013; 128: e240−e327.

[13]

Chinese Society of Cardiology. 2014 CSC Guideline and Recommendation for the Diagnose and Management of Heart Failure. Chin J Cardiol 2014; 42: 98−122.

[14]

Lazar HL, Salm TV, Engelman R, et al. Prevention and management of sternal wound infections. J Thorac Cardiovasc Surg 2016; 152: 962−972.

[15]

Yancy CW, Jessup M, Bozkurt B, et al. 2013 ACCF/AHA guideline for the management of heart failure: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines. Circulation 2013; 128: 1810−1852.

[16]

Di Carli MF, Maddahi J, Rokhsar S, et al. Long-term survival of patients with coronary artery disease and left ventricular dysfunction: implications for the role of myocardial viability assessment in management decisions. J Thorac Cardiovasc Surg 1998; 116: 997−1004.

[17]

Head SJ, Milojevic M, Daemen J, et al. Mortality after coronary artery bypass grafting versus percutaneous coronary intervention with stenting for coronary artery disease: a pooled analysis of individual patient data. Lancet 2018; 391: 939−948.

[18]

Whang W, Bigger JT, Jr. Diabetes and outcomes of coronary artery bypass graft surgery in patients with severe left ventricular dysfunction: results from The CABG Patch Trial database. The CABG Patch Trial Investigators and Coordinators. J Am Coll Cardiol 2000; 36: 1166−1172.

[19]

Pan L, Tan S, Cao L, et al. Risk factor analysis and management strategies of operating room-related infections after coronary artery bypass grafting. J Thorac Dis 2018; 10: 4949−4956.

[20]

Jin L, Zhang GX, Han L, et al. Baseline and Outcome Characteristics of Multiple Valve Surgery Compared with Single Valve Procedures in Mainland China: A Multicenter Experience. Heart Surg Forum 2019; 22: e486−e493.

[21]

Li J, Li X, Wang Q, et al. ST-segment elevation myocardial infarction in China from 2001 to 2011 (the China PEACE-Retrospective Acute Myocardial Infarction Study): a retrospective analysis of hospital data. Lancet 2015; 385: 441−451.

[22]

Hamad MA, van Straten AH, Schonberger JP, et al. Preoperative ejection fraction as a predictor of survival after coronary artery bypass grafting: comparison with a matched general population. J Cardiothorac Surg 2010; 5: 29.

[23]

Topkara VK, Cheema FH, Kesavaramanujam S, et al. Coronary artery bypass grafting in patients with low ejection fraction. Circulation 2005; 112(9 Suppl): I344−I350.

[24]

Michler RE, Rouleau JL, Al-Khalidi HR, et al. Insights from the STICH trial: change in left ventricular size after coronary artery bypass grafting with and without surgical ventricular reconstruction. J Thorac Cardiovasc Surg. 2013; 146: 1139−1145.e6.

[25]

Garg R, Schuman B, Bader A, et al. Effect of Preoperative Diabetes Management on Glycemic Control and Clinical Outcomes After Elective Surgery. Ann Surg 2018; 267: 858−862.

[26]

Giustino G, Mehran R, Serruys PW, et al. Left Main Revascularization With PCI or CABG in Patients With Chronic Kidney Disease: EXCEL Trial. J Am Coll Cardiol 2018; 72: 754−765.

[27]

Weerasinghe A, Hornick P, Smith P, et al. Coronary artery bypass grafting in non-dialysis-dependent mild-to-moderate renal dysfunction. J Thorac Cardiovasc Surg 2001; 121: 1083−1089.

[28]

Devbhandari MP, Duncan AJ, Grayson AD, et al. Effect of risk-adjusted, non-dialysis-dependent renal dysfunction on mortality and morbidity following coronary artery bypass surgery: a multi-centre study. Eur J Cardiothorac Surg 2006; 29: 964−970.

[29]

Brown JR, Cochran RP, Dacey LJ, et al. Perioperative increases in serum creatinine are predictive of increased 90-day mortality after coronary artery bypass graft surgery. Circulation 2006; 114: I409−1413.

[30]

Ueki C, Miyata H, Motomura N, et al. Off-pump technique reduces surgical mortality after elective coronary artery bypass grafting in patients with preoperative renal failure. J Thorac Cardiovasc Surg 2018; 156: 976−983.

[31]

Shroff GR, Li S, Herzog CA. Survival of patients on dialysis having off-pump versus on-pump coronary artery bypass surgery in the United States. J Thorac Cardiovasc Surg 2010; 139: 1333−1338.

[32]

Di Mauro M, Gagliardi M, Iaco AL, et al. Does off-pump coronary surgery reduce postoperative acute renal failure? The importance of preoperative renal function. Ann Thorac Surg 2007; 84: 1496−1502.

[33]

Zangrillo A, Pappalardo F, Dossi R, et al. Preoperative intra-aortic balloon pump to reduce mortality in coronary artery bypass graft: a meta-analysis of randomized controlled trials. Crit Care 2015; 19: 10.

[34]

Chambers DC, Cherikh WS, Harhay MO, et al. The International Thoracic Organ Transplant Registry of the International Society for Heart and Lung Transplantation: Thirty-sixth adult lung and heart-lung transplantation Report-2019; Focus theme: Donor and recipient size match. J Heart Lung Transplant 2019; 38: 1042−1055.

File
20201021001-ESM.pdf (145.2 KB)
Publication history
Copyright
Acknowledgements
Rights and permissions

Publication history

Published: 28 January 2021
Issue date: January 2021

Copyright

© 2021 JGC All rights reserved

Acknowledgements

ACKNOWLEDGEMENTS

The authors thank all China-HFSR investigators and participants for their contributions: Xin Chen, Yingbin Xiao, Fei Li, Feng Wan, Tao Han, Liangwan Chen, Hongyu Liu, Su Liu, Zhaoyun Cheng, Guimin Zhang, Zhongmin Liu, Chunsheng Wang, Huishan Wang, Zhenya Shen, Zhigang Liu, Chengchao Sun, Xinmin Zhou and Yiming Ni.

Rights and permissions

Return